Loading...
XNAS
AQB
Market cap3mUSD
Jul 16, Last price  
0.78USD
1D
0.38%
1Q
20.48%
IPO
-76.47%
Name

AquaBounty Technologies Inc

Chart & Performance

D1W1MN
No data to show
P/E
0.00
P/S
—
EPS
38,557.45
Div Yield, %
—
Shrs. gr., 5y
30.92%
Rev. gr., 5y
96.45%
Revenues
0k
-100.00%
777,575225,779281,07856,8690000000053,27884,518186,738127,6631,174,8323,136,9542,472,6590
Net income
149.19b
P
000-6,656,683000-4,414,613-4,689,038-7,127,375-7,031,512-8,470,661-9,258,647-10,382,059-13,304,620-16,552,564-22,754,649-21,990,852-27,557,901149,192,660,000
CFO
-13.86b
L+57,099.36%
-1,926,736000000-3,715,455-4,457,628-6,560,900-6,748,298-7,448,893-9,100,778-9,816,765-11,248,747-14,288,821-20,472,259-21,006,830-24,236,245-13,862,976,000
Earnings
Aug 04, 2025

Profile

AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.
URL
https://aquabounty.com/
IPO date
Jan 09, 2017
Employees
100
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,473
-21.18%
3,137
167.01%
Cost of revenue
9,524,240
29,698
25,460
Unusual Expense (Income)
NOPBT
(9,524,240)
(27,226)
(22,324)
NOPBT Margin
Operating Taxes
(166)
Tax Rate
NOPAT
(9,524,240)
(27,226)
(22,157)
Net income
149,192,660
-541,478.90%
(27,558)
25.32%
(21,991)
-3.36%
Dividends
Dividend yield
Proceeds from repurchase of equity
1,538
BB yield
Debt
Debt current
1,261,039
826
2,387
Long-term debt
2,043
8,243
6,693
Deferred revenue
Other long-term liabilities
2,017,520
Net debt
1,032,720
856
(93,559)
Cash flow
Cash from operating activities
(13,862,976)
(24,236)
(21,007)
CAPEX
(2,929,908)
(68,890)
(67,476)
Cash from investing activities
7,563,314
(68,893)
34,350
Cash from financing activities
(2,663,712)
(308)
(162)
FCF
(5,776,186)
(93,271)
(94,567)
Balance
Cash
230,362
8,214
101,639
Long term investments
1,000
Excess cash
230,362
8,090
102,482
Stockholders' equity
(370,460,767)
(220,981)
(193,468)
Invested Capital
389,582,056
394,786
394,265
ROIC
ROCE
EV
Common stock shares outstanding
3,860
3,844
3,553
Price
Market cap
EV
EBITDA
(8,620,104)
(25,068)
(20,299)
EV/EBITDA
Interest
2,285,017
304
291
Interest/NOPBT